NanoPass

Activities: Drug Delivery Pharmaceutical

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Drug Delivery

NanoPass and Elcam Medical enter partnership

Sign investment and manufacturing agreement for advanced drug delivery system
Regulatory

NanoPass microneedle device provides significant dose sparing

<p>NanoPass Technologies of Israel has developed a microneedle-based device that it says could dramatically enhance both the effectiveness and supply of pandemic flu vaccines.</p>

GSK pioneers new vaccine

MicroPyramid vaccine delivery to be developed

GSK and NanoPass Technologies to develop MicroPyramid-based vaccine delivery

Medical device company NanoPass Technologies, based in Haifa in Israel, has signed an agreement with GlaxoSmithKline\'s biopharmaceutical centre of excellence for drug discovery (CEDD) to develop its MicroPyramid technology for the delivery of vaccines.
Subscribe now